Servicio Digestivo ICS-Intitut d'Assistència Sanitària. Hospital Santa Caterina. Salt. Girona.
Agència de Salut Pública de Catalunya. Generalitat de Catalunya.
Gastroenterol Hepatol. 2021 Nov;44(9):614-619. doi: 10.1016/j.gastrohep.2021.03.001. Epub 2021 Apr 20.
Healthcare professionals in endoscopy units have a possible risk of SARS-CoV-2 infection by different routes: inhalation of airborne droplets, aerosols, conjunctival contact and faecal-oral transmission.
To describe the detection of SARS-CoV-2 in a series of patients scheduled for digestive endoscopy at the Hospital Santa Caterina. Salt. (Girona).
Descriptive study of a series of cases of patients scheduled for endoscopy during the month of May 2020, when endoscopic activity was resumed after the peak of the pandemic, following SCD, SEED, AEG and ESGE recommendations. We examined nasopharyngeal samples 48-72 hours before the appointment, by RT-PCR, in all patients. RNA extraction was performed using the kits: Qiagen®-adapted, BiosSprint®96-DNA-Blood-Kit (384). For amplification-detection of SARS-CoV-2, methods recommended by the WHO and the CDC were followed.
110 asymptomatic patients without close contact with a positive case in the previous 14 days were scheduled; 105 (96.4%) were negative and five (4.5%) were positive. Two patients developed respiratory symptoms after diagnosis (presymptomatic) and three remained asymptomatic. Allfive5 patients were autochthonous cases with no history of travel or residence in another city or country associated with high prevalence of infection. Four cases were women aged 60-81 years. The N gene was detected in all cases.
A high prevalence of SARS-CoV-2 infection was detected in patients scheduled for digestive endoscopy. Given the risk of transmission to professionals, we consider it advisable to perform SARS-CoV-2 RT-PCR 48-72 hours before the examination in situations of high incidence in the population.
描述在圣卡特琳娜医院(Girona)的一系列拟行消化内镜检查的患者中检测到 SARS-CoV-2 的情况。
对 2020 年 5 月期间拟行内镜检查的一系列患者进行描述性研究,当时在遵循 SCD、SEED、AEG 和 ESGE 建议后,大流行高峰期过后恢复了内镜检查活动。我们对所有患者在预约前 48-72 小时进行了鼻咽样本的 RT-PCR 检测。RNA 提取采用 Qiagen®-adapted、BiosSprint®96-DNA-Blood-Kit(384)试剂盒进行。为了扩增和检测 SARS-CoV-2,我们遵循了世界卫生组织和美国疾病控制与预防中心推荐的方法。
110 名无症状患者,在过去 14 天内没有与阳性病例的密切接触,其中 105 名(96.4%)为阴性,5 名(4.5%)为阳性。诊断后有两名患者出现呼吸道症状(出现症状前),还有三名患者无症状。所有 5 例患者均为本地病例,无旅行史或居住在与高感染率相关的其他城市或国家的病史。4 例为 60-81 岁女性。所有病例均检测到 N 基因。
在拟行消化内镜检查的患者中检测到 SARS-CoV-2 感染的高流行率。鉴于向专业人员传播的风险,我们认为在人群发病率高的情况下,建议在检查前 48-72 小时进行 SARS-CoV-2 RT-PCR。